- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06693557
Feeding Intolerance in Preterm Infant
November 15, 2024 updated by: Hager Amer Nadi Abdelaziz, Assiut University
Feeding Intolerance in Preterm Infant ,Rate of Occurrences, Risk Factors , Outcomes
To determine the incidence and risk factors of feeding intolerance in preterm infants.
To assess the outcome of feeding intolerance in preterm infants.
Study Overview
Status
Not yet recruiting
Conditions
Detailed Description
Premature infants frequently suffer from feeding intolerance related to prematurity and are highly associated with morbidity and mortality.
[1] Feeding intolerance (FI) is defined as difficulty to digest enteral feedings and is accompanied by an increase in gastric residuals, abdominal distension, and/or reflux.
It is common in preterm infants and commonly results in feeding and gastrointestinal disruptions.
FI in newborns can be a sign of a variety of problems, ranging from minor, self-limiting illnesses to serious, life-threatening illnesses.
[2] The common cause of FI is low intestinal motility because of prematurity , Enzymatic digestion, bacterial colonization, hormonal response, and local immunity are also possible reasons for FI.
[3] FI is very common among preterm infants and its clinical symptoms include abdominal distension, vomiting, bilious gastric residuals, occult or gross bloody stools, and are observed in nearly 29% of such neonates.
[4] Factors that contribute to feeding intolerance include poor coordination of sucking and swallowing, incompetent lower esophageal sphincter, small gastric capacity, delayed gastric emptying time, and intestinal hypomotility.
Abnormal bacterial colonization may be a coexisting factor in feeding intolerance in newborns mainly due to dysfunction of the intestinal barrier, the immune responses, and sensory motor functions of the gut.
[5] Mother's milk feeding is related to better feeding tolerance and may be correlated to a reduction in severe morbidity.
[6] The mode of delivery (vaginal or cesarean section) and feeding type (breastfeeding or formula feeding) of neonates are considered the most influential factors in the development of gut microbiota.
[7] In the preterm infant, the readiness to tolerate enteral nutrition relies upon the degree of maturation of gastro-intestinal (G-I) functions (motility, enzymatic digestion, hormonal responses, bacterial colonization and local immunity).
Anatomical development of the GI tract is largely completed at 20 weeks of gestation, although the elongation of the GI tube and increases in the absorbing area (microvilli) continue during the last trimester of gestation and beyond.
[8] Successful establishment of enteral feedings is a major goal in the treatment of very low-birthweight infants, but functional immaturity of the gastrointestinal tract may hamper such efforts.
Prokinetic agents often are used in an attempt to overcome functional immaturity by speeding up gastric empyting and increase intestinal wall motility.[9]
Study Type
Observational
Enrollment (Estimated)
63
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Hager Amer Abdelaziz, Bachelor of medicine
- Phone Number: 01023762165
- Email: amerhager941@gmail.com
Study Contact Backup
- Name: Gafar Ibrahim Mohamed, Professor
- Phone Number: 01020627864
- Email: Gafar.ibrahim@med.au.edu.eg
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
Preterm infants less than 37 weeks
Description
Inclusion Criteria:
- Preterm infants (gestational age < 37 weeks).
- Preterm infants from day 0 to day 28 of life.
Exclusion Criteria:
- We will exclude those babies:
- Full-term babies (gestational age > 37 weeks).
- Preterm babies with gastrointestinal anomalies.
- Preterm babies with suspected inborn errors of metabolism.
- Preterm babies with suspected necrotizing enterocolitis and sepsis at the onset of feeding.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To determine the incidence and risk factors of feeding intolerance in preterm infants. To assess the outcome of feeding intolerance in preterm infants
Time Frame: Baseline
|
To determine the incidence and risk factors of feeding intolerance in preterm infants.by
assessment of extremely low birth with congenital heart disease by echo , Respiratory distress syndrome by chest x ray In order to determine : A_ Daily weight gain by BMI B_ Days to reach fulfill feeding C_ Duration of hospital stay.
|
Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
January 1, 2025
Primary Completion (Estimated)
December 30, 2025
Study Completion (Estimated)
January 30, 2026
Study Registration Dates
First Submitted
November 13, 2024
First Submitted That Met QC Criteria
November 15, 2024
First Posted (Estimated)
November 18, 2024
Study Record Updates
Last Update Posted (Estimated)
November 18, 2024
Last Update Submitted That Met QC Criteria
November 15, 2024
Last Verified
November 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- Feeding intolernce
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Feeding Intolernce
-
The Hong Kong Polytechnic UniversityCompletedParents | Breast Feeding, ExclusiveHong Kong
-
Loma Linda UniversityNot yet recruitingPregnancy Related | Breast Feeding, ExclusiveUnited States
-
Sakarya UniversityNot yet recruitingBreast Feeding | Feeding BehaviorTurkey
-
Centre Hospitalier Intercommunal CreteilCompletedFeeding Behavior | Feeding, BottleFrance
-
Société des Produits Nestlé (SPN)Completed
-
London School of Hygiene and Tropical MedicineFHI 360; AFRICSante; Centre MurazCompleted
-
Emel GÜÇLÜ CİHANKahramanmaras Sutcu Imam UniversityRecruitingBreast Feeding | Primiparity | Exclusive Breast Feeding | Maternal-Fetal AttachmentTurkey (Türkiye)
-
University Hospitals Cleveland Medical CenterCompleted
-
Amasya UniversityMustela FoundationEnrolling by invitation
-
Gelre HospitalsMedisch Spectrum TwenteRecruitingFeeding Disorders | Feeding Tube ComplicationNetherlands